Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod

Dermatologic Surgery

Volumn 34, Issue 6, 2008, Pages 844-845

  Jacob, Sharon E ^a   Blyumin, Mariana ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; BENZYL ALCOHOL; CATECHOL DERIVATIVE; CHLOROQUINE; CINNAMIC ACID; CORTICOSTEROID; HYDROQUINONE; IMIQUIMOD; MERCURY; PHENOL; PHENYLENEDIAMINE; PHYSOSTIGMINE; THIOL DERIVATIVE;

AGED; APPLICATION SITE REACTION; ARTICLE; BASAL CELL CARCINOMA; BURNING SENSATION; CASE REPORT; DECISION MAKING; DIFFERENTIAL DIAGNOSIS; EDEMA; EROSION; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HYPOPIGMENTATION; LEUKODERMA; MALE; POLIOSIS; PRIORITY JOURNAL; PRURITUS; SKIN CRUSTING; SKIN INDURATION; SKIN SCALING; VITILIGO;

AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; HUMANS; HYPOPIGMENTATION; MALE; SKIN NEOPLASMS; THORAX;

EID: 44849118329     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2008.34158.x     Document Type: Article

References (8)

1. Ortonne JP. Vitiligo and other disorders of hypopigmentation. In:Bolognia JL, Jorizzo J, Rapini R, editors. Dermatology. London:CV Mosby 2003. p. 947 1004.
2. Aldara [package insert]. St. Paul, Minnesota: 3M Pharmaceuticals, 2004. (accessed February 26, 2008).
3. Geisse J, Caro I, Lindholm J, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50:722 33.
4. Stefanaki C, Nicolaidou E, Hadjivassiliou M, et al. Imiquimod-induced vitiligo in a patient with genital warts. J Eur Acad Dermatol Venereol 2006 20:755 6.
5. Brown T, Zirvi M, Cotsarelis G, Gelfand JM. Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts. J Am Acad Dermatol 2005 52:715 6.
6. Gollnick H, Guillen Barona C, Frank RG, et al. Efficacy by clinical evaluation of imiquimod 5% cream in the treatment of superficial basal cell carcinoma: initial results from an ongoing, long-term follow-up study in Europe. J Am Acad Dermatol 2004 50:124.
7. Mendonca CO, Yates VM. Permanent facial hypopigmentation following treatment with imiquimod cream. Clin Exp Dermatol 2006 31:721 2.
8. Taylor JS, Maibach HI, Fisher AA, Bergfeld WF. Contact leukoderma associated with the use of hair colors. Cutis 1993 52:273 80.